MyFinsight
Home
Blog
About
Tectonic Therapeutic, Inc. (TECX)
Tectonic Therapeutic, Inc. (TECX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$21,530K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the at-the-market ...
Stock-based compensation expense
Reduction in the carrying amount...
Others
Negative Cash Flow Breakdown
Net loss
Accrued expenses and other curre...
Prepaid expenses and other curre...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-22,285
-25,241
-19,226
-19,035
Depreciation and amortization expense
285
304
333
342
Stock-based compensation expense
4,012
3,205
2,989
2,817
Loss on disposal of property and equipment
0
-23
0
-93
Reduction in the carrying amount of the operating right-of-use assets
429
496
548
535
Change in fair value of safe liabilities
-
-
0
0
Prepaid expenses and other current assets
1,131
46
-1,246
753
Othernon-currentassets
-37
23
-14
5
Accounts payable
-799
1,383
-343
-1,262
Accrued expenses and other current liabilities
-1,861
1,633
571
34
Operating lease liabilities
-138
-147
-593
-581
Net cash used in operating activities
-21,451
-18,413
-14,461
-17,815
Purchase of property and equipment
79
19
0
181
Proceeds from the sale of property and equipment
20
-
0
15
Net cash (used in) provided by investing activities
-59
-19
0
-166
Proceeds from the at-the-market offering, net of offering costs
11,811
1,264
-
-
Proceeds from the private placement, net of offering costs
0
0
0
0
Proceeds from the subscription agreement, net of offering costs of 2,000
-
-
0
0
Cash acquired in connection with the merger, net of transaction costs of 7,412
-
-
0
0
Proceeds from exercise of stock options
44
100
59
6
Payments for employee taxes related to net share settlement of equity awards
77
412
0
0
Payment of deferred offering costs
-
-
-73
-340
Repayment of finance lease obligations
96
105
127
123
Net cash provided by financing activities
11,682
847
-141
-457
Effect of exchange rate changes on cash and cash equivalents
2
94
-35
-23
Net (decrease) increase in cash and cash equivalents and restricted cash
-9,826
-17,491
-14,637
-18,461
Cash and cash equivalents and restricted cash as of beginning of period
237,379
254,870
269,507
141,826
Cash and cash equivalents and restricted cash as of end of period
227,553
-
-
-
Cash and cash equivalents
227,068
-
-
-
Restricted cash
485
-
-
-
Total cash, cash equivalents and restricted cash
227,553
237,379
254,870
269,507
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
at-the-market offering, net of...
$11,811K
Proceeds from exercise of
stock options
$44K
(-96.23%↓ Y/Y)
Net cash provided by
financing activities
$11,682K
(-93.28%↓ Y/Y)
Effect of exchange rate
changes on cash and cash...
$2K
(105.41%↑ Y/Y)
Canceled cashflow
$173K
Net (decrease)
increase in cash and cash...
-$9,826K
(-106.72%↓ Y/Y)
Canceled cashflow
$11,684K
Stock-based compensation
expense
$4,012K
(-14.47%↓ Y/Y)
Reduction in the carrying
amount of the operating...
$429K
(-58.55%↓ Y/Y)
Depreciation and
amortization expense
$285K
(-59.29%↓ Y/Y)
Othernon-currentassets
-$37K
(-362.50%↓ Y/Y)
Proceeds from the sale of
property and equipment
$20K
(-63.64%↓ Y/Y)
Repayment of finance lease
obligations
$96K
(-59.83%↓ Y/Y)
Payments for employee
taxes related to net...
$77K
(352.94%↑ Y/Y)
Net cash used in
operating activities
-$21,451K
(22.84%↑ Y/Y)
Canceled cashflow
$4,763K
Net cash (used in)
provided by investing...
-$59K
(-310.71%↓ Y/Y)
Canceled cashflow
$20K
Net loss
-$22,285K
(37.91%↑ Y/Y)
Accrued expenses and
other current...
-$1,861K
(-60.85%↓ Y/Y)
Prepaid expenses and
other current assets
$1,131K
(152.58%↑ Y/Y)
Accounts payable
-$799K
(-146.43%↓ Y/Y)
Operating lease
liabilities
-$138K
(87.69%↑ Y/Y)
Purchase of property and
equipment
$79K
(192.59%↑ Y/Y)
Buy us a coffee